Cargando...

The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer's Disease

BACKGROUND: Vascular risk factors (VRF) may influence response to rivastigmine in Alzheimer's disease (AD). METHODS: AD patients who participated in a randomized, double-blind, placebo-controlled trial of rivastigmine patch and capsule treatment were stratified by baseline VRF status. Treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Farlow, M.R., Doraiswamy, P.M., Meng, X., Cooke, K., Somogyi, M.
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3199893/
https://ncbi.nlm.nih.gov/pubmed/22163241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000328745
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!